Drug treatment of common STDs: part I. Herpes, syphilis, urethritis, chlamydia and gonorrhea.

Abstract

In 1998, the Centers for Disease Control and Prevention released guidelines for the treatment of sexually transmitted diseases. Several treatment advances have been made since the previous guidelines were published. Part I of this two-part article describes current recommendations for the treatment of genital ulcer diseases, urethritis and cervicitis. Treatment advances include effective single-dose regimens for many sexually transmitted diseases and improved therapies for herpes infections. Two single-dose regimens, 1 g of oral azithromycin and 250 mg of intramuscular ceftriaxone, are effective for the treatment of chancroid. A three-day course of 500 mg of oral ciprofloxacin twice daily may be used to treat chancroid in patients who are not pregnant. Parenteral penicillin continues to be the drug of choice for treatment of all stages of syphilis. Three antiviral medications have been shown to provide clinical benefit in the treatment of genital herpes: acyclovir, valacyclovir and famciclovir. Valacyclovir and famciclovir are not yet recommended for use during pregnancy. Azithromycin in a single oral 1-g dose is now a recommended regimen for the treatment of nongonococcal urethritis.

• Authors: C Woodward, M A Fisher
• Journal: American family physician (Am Fam Physician) Vol. 60 Issue 5 Pg. 1387-94 (Oct 01 1999) ISSN: 0002-838X [Print] United States
• PMID: 10524484 (Publication Type: Journal Article)

Chemical References

• Anti-Infective Agents

Topics

• Anti-Infective Agents (therapeutic use)
• Chancroid (drug therapy)
• Chlamydia Infections (drug therapy)
• Female
• Genital Diseases, Female (drug therapy, microbiology)
• Gonorrhea (drug therapy)
• Herpes Genitalis (drug therapy)
• Humans
• Sexually Transmitted Diseases (drug therapy)
• Syphilis (drug therapy)
• Urethritis (drug therapy)
• Uterine Cervicitis (drug therapy)